Molecular Imaging and Radionuclide Therapy

Scope & Guideline

Transforming research into practice in molecular imaging.

Introduction

Immerse yourself in the scholarly insights of Molecular Imaging and Radionuclide Therapy with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageMulti-Language
ISSN2146-1414
PublisherGALENOS PUBL HOUSE
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2017 to 2024
AbbreviationMOL IMAGING RADIONUC / Mol. Imaging Radionucl. Ther.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The journal 'Molecular Imaging and Radionuclide Therapy' is dedicated to advancing the field of molecular imaging and therapy through innovative research that bridges nuclear medicine, radiology, and oncology. It emphasizes the importance of imaging techniques for diagnosis, treatment planning, and monitoring therapeutic responses in various malignancies and other diseases.
  1. Molecular Imaging Techniques:
    Focuses on the development and application of advanced imaging modalities, such as PET, SPECT, and CT, to visualize biological processes at the molecular and cellular levels.
  2. Radionuclide Therapy:
    Explores the therapeutic applications of radionuclides in treating various cancers, including the mechanisms of action, efficacy, and safety profiles of different radiopharmaceuticals.
  3. Diagnosis and Treatment Monitoring:
    Aims to improve diagnostic accuracy and treatment outcomes through imaging techniques that allow for the evaluation of treatment responses and the identification of disease recurrence.
  4. Clinical Applications in Oncology:
    Highlights the role of molecular imaging in oncology, particularly in the detection, characterization, and staging of tumors, as well as in personalized treatment approaches.
  5. Interdisciplinary Research:
    Encourages collaboration between researchers, clinicians, and industry to foster innovations in imaging and therapy, combining insights from nuclear medicine, radiology, and pathology.
The landscape of research in 'Molecular Imaging and Radionuclide Therapy' is evolving, with several emerging themes reflecting current trends in the field. These themes indicate areas of heightened interest and potential growth.
  1. Novel Radiopharmaceuticals:
    A growing body of research is focusing on the development and clinical application of novel radiopharmaceuticals, particularly those targeting specific molecular markers in cancers.
  2. Theranostics:
    The integration of therapeutic and diagnostic approaches, known as theranostics, is increasingly prevalent, allowing for personalized treatment strategies based on imaging findings.
  3. Artificial Intelligence in Imaging:
    The application of artificial intelligence and machine learning techniques for image analysis and interpretation is emerging as a significant trend, enhancing diagnostic accuracy and workflow efficiency.
  4. Immuno-PET Imaging:
    Research on immuno-PET, which combines immunotherapy with PET imaging to monitor treatment response, is gaining traction as a promising area for personalized cancer management.
  5. Radiomics and Texture Analysis:
    The use of radiomics to extract quantitative features from imaging data for predicting treatment outcomes and tumor characteristics is increasingly popular, reflecting the trend towards data-driven approaches in oncology.

Declining or Waning

While the journal maintains a strong focus on cutting-edge research, certain themes have seen a decline in prominence over recent years. This section identifies these waning scopes, reflecting shifts in research interests and advancements in technology.
  1. Non-Oncological Applications:
    Research focusing on non-oncological applications of molecular imaging and radionuclide therapy has decreased, as the field has increasingly concentrated on oncology-related studies.
  2. Older Imaging Techniques:
    There is a noticeable decline in publications centered around older imaging techniques that have been largely supplanted by more advanced methodologies, such as PET/CT and hybrid imaging.
  3. Basic Science Studies:
    The journal has shifted towards more clinically oriented research, resulting in fewer publications that focus solely on the basic science aspects of imaging and therapy.
  4. Traditional Radiopharmaceuticals:
    Research on traditional radiopharmaceuticals that do not incorporate newer imaging technologies or innovative therapeutic approaches is becoming less frequent.

Similar Journals

Indian Journal of Nuclear Medicine

Advancing Insights in Nuclear Medicine
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-3919Frequency: 4 issues/year

Indian Journal of Nuclear Medicine, published by Wolters Kluwer Medknow Publications, serves as a crucial platform for advancing knowledge and research in the field of nuclear medicine, a specialized domain crucial for diagnostic imaging and therapy. With an ISSN of 0972-3919 and an E-ISSN of 0974-0244, this esteemed journal has been a trusted source of information from 2010 to 2024. Situated in Mumbai, India, it caters to researchers and professionals with an interest in the interplay between radiology and innovative nuclear imaging techniques. Although classified as Q4 in Radiology, Nuclear Medicine, and Imaging in 2023, the journal actively contributes to the dialogue surrounding emerging technologies, clinical practices, and challenges in nuclear medicine, making it a significant addition to the academic discourse. While currently not categorized as Open Access, readers can benefit from the wealth of peer-reviewed articles that shape the future of nuclear medicine and its applications. As the impact factor and specific H-index details are not listed, the journal's potential for future growth and increased visibility in the academic community remains promising, positioning it as a commendable resource for students, researchers, and healthcare professionals dedicated to the advancement of medical imaging and therapy.

BRITISH JOURNAL OF RADIOLOGY

Advancing Radiology Through Innovation and Excellence
Publisher: BRITISH INST RADIOLOGYISSN: 0007-1285Frequency: 12 issues/year

British Journal of Radiology is a leading peer-reviewed journal published by the British Institute of Radiology, dedicated to advancing the field of radiology, nuclear medicine, and imaging. With a prestigious history dating back to 1945, this journal is at the forefront of disseminating cutting-edge research and innovations that significantly impact clinical practice. Currently enjoying a Q1 ranking in the field of radiology and Q2 in general medicine for 2023, it is recognized for its rigorous standards and high-quality content, ranking #87 out of 333 in Scopus for specialties related to Medicine, Radiology, Nuclear Medicine, and Imaging, placing it in the 74th percentile. Researchers, professionals, and students are encouraged to engage with the latest findings and comprehensive reviews presented within its pages, which contribute not only to academic discourse but also to the evolution of practice in the wider medical community.

Hellenic Journal of Nuclear Medicine

Advancing Nuclear Medicine Knowledge Globally
Publisher: HELLENIC SOC NUCLEAR MEDICINEISSN: 1108-1430Frequency: 3 issues/year

The Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.

Indian Journal of Radiology and Imaging

Innovative Insights in Imaging and Nuclear Medicine
Publisher: THIEME MEDICAL PUBL INCISSN: 0971-3026Frequency: 4 issues/year

The Indian Journal of Radiology and Imaging, published by THIEME MEDICAL PUBL INC, is a prominent open-access journal in the field of radiology, nuclear medicine, and imaging. Since its inception in 1984, the journal has provided a platform for researchers, professionals, and students to disseminate innovative research and findings in diagnostic imaging. With a growing impact factor and categorized in the Q3 quartile according to the 2023 rankings, it ranks among the notable journals in its field, although it currently stands at Rank #244 out of 333 within Scopus, reflecting its competitive position in radiology research. The journal, accessible to a global audience since 1999, aims to advance the knowledge and practice in imaging by inviting diverse contributions, including original research articles, reviews, and case reports. Its commitment to open-access publication fosters wider dissemination and collaborative discourse, crucial for the dynamic landscape of medical imaging.

EJNMMI Physics

Pioneering Research in Radiology and Nuclear Medicine.
Publisher: SPRINGERISSN: 2197-7364Frequency: 1 issue/year

EJNMMI Physics, the premier journal for advancements in nuclear medicine and imaging, is published by Springer in Switzerland and has been an open-access outlet since 2014, allowing for broad dissemination of critical research findings. With an ISSN of 2197-7364, the journal aims to bridge the gap between state-of-the-art physics and practical applications in biomedical engineering and radiology. Its impressive Q1 ranking in multiple categories, including Biomedical Engineering, Instrumentation, Radiation, and Radiology, Nuclear Medicine and Imaging, exemplifies its significant impact in the field. The journal boasts exceptional metrics with Scopus rankings placing it in the top echelons across disciplines, including a 6th position out of 58 in Radiation, and serves as an essential resource for researchers, professionals, and students who are eager to contribute to and stay informed about cutting-edge scientific advancements. With a broadening scope until 2024, EJNMMI Physics is an indispensable tool for those dedicated to pushing the boundaries of knowledge in medical physics and imaging technologies.

CANCER IMAGING

Connecting Researchers to the Future of Cancer Imaging
Publisher: BMCISSN: 1740-5025Frequency: 1 issue/year

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN

Pioneering Insights for Modern Diagnostic Practices
Publisher: GEORG THIEME VERLAG KGISSN: 1438-9029Frequency: 12 issues/year

ROFO-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, published by Georg Thieme Verlag KG, is a pivotal journal in the fields of radiology and nuclear medicine, offering invaluable insights for researchers, healthcare professionals, and students alike. With an ISSN of 1438-9029, this journal has been a stalwart of scientific communication since its inception in 1975, actively contributing to advancements in imaging techniques and radiation therapy. Although it operates under traditional access, the journal maintains a respectable standing, reflected by its Q3 ranking in Radiology, Nuclear Medicine and Imaging and Q4 in Medicine (miscellaneous), highlighting its significance in the scholarly community. Its coverage spans a wide array of topics pertinent to diagnostic imaging and therapy protocols, making it an essential resource for anyone seeking to understand the complexities of modern radiological practices. As the journal continues to evolve through 2024, it invites contributions that enrich the dialogue around technological innovations and clinical applications in the realm of imaging modalities.

Molecular Imaging

Transforming Insights into Innovations in Imaging.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Molecular Imaging is a prominent journal published by SAGE Publications Inc., which serves as a vital platform for the dissemination of high-quality research in the field of molecular imaging. With an E-ISSN of 1536-0121, this journal has established itself within several key areas, including Biomedical Engineering, Biotechnology, Condensed Matter Physics, Molecular Medicine, and Radiology, Nuclear Medicine and Imaging. Spanning from 2002 to 2024 and currently classified within the prestigious Q2 and Q3 quartiles, Molecular Imaging aims to highlight the latest developments and innovative methodologies in molecular imaging techniques and applications. Researchers from diverse backgrounds will find the journal's content valuable for staying updated with recent advancements, evidenced by its competitive Scopus ranking and a commitment to fostering interdisciplinary collaboration. Although the journal is not open access, the rigorous peer-review process ensures that all published articles provide significant contributions to the field, making it an essential resource for professionals, researchers, and students alike.

NUCLEAR MEDICINE COMMUNICATIONS

Illuminating Innovations in Diagnostics and Therapy
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0143-3636Frequency: 12 issues/year

NUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.

Japanese Journal of Radiology

Connecting Researchers and Practitioners in Radiology
Publisher: SPRINGERISSN: 1867-1071Frequency: 10 issues/year

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.